V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002424 | 240010271 | 0 | 78.2 | Curative (C) | 2021-12-15 | 2021-12-16 | DA | 02 | null | CISPLATIN + CYTARABINE + ETOPOSIDE | 100682624 |
| 240002427 | 240010273 | 1.9 | 82.8 | Curative (C) | 2019-09-25 | 2019-10-02 | DA | 02 | null | ETOPOSIDE | 100828896 |
| 240002428 | 240010274 | 1.64 | 97 | null | 2016-11-20 | 2016-11-21 | null | 02 | null | MELPHALAN | 101526696 |
| 240002430 | 240010275 | 0 | 28.1 | Curative (C) | 2020-06-12 | 2020-07-06 | ALL Interim Guide 2019 Consolidation A | 01 | null | PEMBROLIZUMAB | 100702960 |
| 240002437 | 240010277 | 1.9 | 74.7 | 03 | 2022-02-09 | 2022-02-09 | CLADRIBINE | 2 | N | CYTARABINE HIGH DOSE | 101505664 |
| 240002444 | 240010278 | 1.83 | 63.1 | null | 2019-05-02 | 2019-05-05 | GEMTUZUMAB OZOGAMICIN | 02 | null | ALL UKALL2011 AUG BFM CONS C | 100239144 |
| 240002447 | 240010279 | 1.77 | 78 | null | 2017-04-02 | 2017-08-05 | DA 3 + 10 | 01 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100679385 |
| 240002448 | 240010280 | 1.62 | 51.6 | null | null | 2020-06-07 | null | null | null | IBRUTINIB | 100616707 |
| 240002454 | 240010282 | 0 | 17.1 | null | null | 2016-12-02 | IPILIMUMAB + NIVOLUMAB | null | null | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 100455766 |
| 240002458 | 240010283 | 1.62 | 78 | Curative (C) | 2022-01-09 | 2022-01-13 | CYCLO + RITUXIMAB + VINCRISTINE | N | null | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE | 101461048 |
| 240002475 | 240010285 | 1.12 | 43 | 03 | 2019-01-14 | 2019-01-23 | Trial Unspecified | 02 | null | AZACITIDINE + VENETOCLAX | 101163175 |
| 240002478 | 240010286 | 1.56 | 71.1 | null | 2018-10-31 | 2018-11-09 | R CODOX M | null | N | ALL UKALL2011 CAP INT MAINT C | 100059700 |
| 240002486 | 240010287 | 1.68 | 76 | Curative (C) | 2019-01-23 | 2019-01-23 | IVAC | 02 | null | ETOPOSIDE PBSCT MOBILISAT (1.6G/M2) | 101706950 |
| 240002494 | 240010290 | 1.6 | 133 | 03 | null | 2020-04-16 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | N | N | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 101692205 |
| 240002529 | 240010293 | 1.56 | 84 | null | 2020-09-02 | 2020-09-02 | ALL UKALL2011 Aug BFM Cons C PegAsp | null | null | VENETOCLAX | 101794967 |
| 240002530 | 240010294 | 1.67 | 70 | Curative (C) | 2016-03-24 | 2016-04-28 | Cytarabine High Dose | 02 | null | CYCLOPHOSPHAMIDE | 101456655 |
| 240002533 | 240010296 | 1.5 | 91.2 | null | 2018-04-24 | 2018-05-09 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | AML DOWNS AIE | 100183101 |
| 240002539 | 240010297 | 1.91 | 52.2 | Adjuvant (A) | 2018-12-12 | 2018-12-14 | CYTARABINE + DAUNORUBICIN + Gemtuzumab Ozogamicin | 02 | N | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100615225 |
| 240002542 | 240010298 | 1.84 | 73.7 | Curative (C) | 2021-10-30 | 2021-11-04 | null | 02 | null | DABRAFENIB | 101652203 |
| 240002543 | 240010299 | null | null | Curative (C) | 2021-11-29 | 2021-11-29 | ALL UKALL2011 Maintenance A2 | N | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100371794 |
| 240002552 | 240010302 | 1.67 | 57.2 | null | 2020-12-30 | 2021-03-11 | null | Y | N | ALL ALLR3: S/IR CONS | 100131616 |
| 240002553 | 240010303 | 1.66 | 90 | null | 2017-05-04 | 2017-05-26 | CYCLOPHOSPHAMIDE + FLUDARABINE | 01 | null | METHOTREXATE INTRATHECAL | 100040788 |
| 240002563 | 240010304 | 1.76 | 80.4 | null | 2019-05-06 | 2019-05-06 | AML MyeChild 01 HD AraC | 02 | null | APML ATRA | 100236291 |
| 240002565 | 240010305 | 1.71 | 80.4 | Curative (C) | 2018-12-09 | 2018-12-09 | R GCVP | null | N | BUSULFAN | 100932525 |
| 240002577 | 240010308 | 1.75 | 106.6 | Disease modification (D) | 2020-12-05 | 2020-12-07 | null | 02 | null | AML MYECHILD | 101309020 |
| 240002578 | 240010309 | 1.67 | 51.3 | 03 | 2019-10-11 | 2019-10-12 | CYTARABINE + DAUNORUBICIN + Gemtuzumab Ozogamicin | 02 | null | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101858176 |
| 240002580 | 240010310 | 1.78 | 74 | null | null | 2021-01-08 | Cladribine (subcut) 5 days | null | null | CYCLOPHOSPHAMIDE | 100624205 |
| 240002583 | 240010311 | 1.6 | 82.3 | null | null | 2021-08-16 | Cytarabine High Dose | 02 | N | ALL UKALL2011 IND B | 100560456 |
| 240002596 | 240010312 | 1.67 | 107.9 | Curative (C) | null | 2017-07-28 | null | null | N | ALL ALLR3: S/IR CONS | 100426877 |
| 240002597 | 240010313 | 1.62 | 53.9 | Curative (C) | null | 2018-10-12 | ALL UKALL2011 Aug BFM Cons C PegAsp | null | N | DASATINIB | 101029319 |
| 240002604 | 240010314 | 1.69 | 85.5 | Curative (C) | 2016-11-11 | 2018-01-10 | AML Int Guide HD Cytarabine (3 + 4) | 02 | null | CYTARABINE + ETOPOSIDE + IFOSFAMIDE | 100898534 |
| 240002610 | 240010315 | 1.74 | 57.9 | Curative (C) | 2019-11-05 | 2019-12-31 | TRANSPLANT BEAM | 01 | N | POMALIDOMIDE | 100238819 |
| 240002612 | 240010316 | 1.76 | 10.4 | Curative (C) | 2021-03-02 | 2021-03-08 | null | 02 | null | CARBOPLATIN + VINCRISTINE | 100396553 |
| 240002613 | 240010317 | 1.59 | 26.5 | 03 | 2016-07-05 | 2016-07-05 | null | 02 | N | RUXOLITINIB | 101654756 |
| 240002619 | 240010319 | 1.83 | 102.6 | 03 | 2019-08-12 | 2019-08-18 | null | 02 | null | ALL UKALL2011 DEL INT A | 101456528 |
| 240002620 | 240010320 | 1.7 | 28.4 | Disease modification (D) | 2020-04-19 | 2020-05-15 | Cytarabine High Dose | 01 | null | IMATINIB | 100852396 |
| 240002631 | 240010322 | 1.9 | 79.7 | null | 2019-03-22 | 2019-05-30 | null | 2 | null | RUXOLITINIB | 100610839 |
| 240002632 | 240010323 | 1.77 | 31.9 | null | 2016-05-25 | 2016-06-10 | FLAG + Idarubicin | 02 | null | NOT MATCHED | 100420743 |
| 240002637 | 240010324 | null | 117 | null | 2018-02-23 | 2018-02-23 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | null | ALL UKALL2011 MAINTENANCE | 100056675 |
| 240002651 | 240010326 | 1.54 | 0 | Curative (C) | 2017-11-30 | 2017-12-10 | null | 02 | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100487371 |
| 240002657 | 240010327 | 1.76 | 65 | 03 | 2020-01-31 | 2020-02-12 | Trial Unspecified | 02 | null | GEMTUZUMAB OZOGAMICIN | 100373006 |
| 240002661 | 240010329 | null | 9.5 | Curative (C) | 2020-01-06 | 2020-01-07 | null | 02 | N | MIDOSTAURIN | 100392129 |
| 240002681 | 240010331 | 0 | 88 | Curative (C) | null | 2017-03-22 | Bortezomib + Cyclophos + Dex | null | null | NOT MATCHED | 101392613 |
| 240002691 | 240010332 | 1.76 | 58.1 | null | 2018-06-01 | 2018-06-28 | IBRUTINIB | 02 | null | BUSULFAN | 101090800 |
| 240002697 | 240010333 | 1.66 | 77 | null | 2019-03-09 | 2019-04-02 | CYCLO + RITUXIMAB + VINCRISTINE | null | null | RUXOLITINIB | 100451551 |
| 240002702 | 240010334 | 0 | 85 | null | 2019-11-08 | 2020-01-01 | CHOP - 21 days | 02 | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101607922 |
| 240002704 | 240010335 | 1.7 | 112.9 | Curative (C) | null | 2021-04-04 | IMATINIB | null | N | ANAGRELIDE | 101247286 |
| 240002710 | 240010337 | 1.5 | 121.1 | Not known (9) | 2021-08-04 | 2021-08-04 | IBRUTINIB | 02 | null | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 100363568 |
| 240002733 | 240010344 | 1.8 | 73.7 | 03 | 2021-05-10 | 2021-05-10 | null | 01 | N | PEG INTERFERON | 101528355 |
| 240002737 | 240010345 | 1.7 | 77 | null | 2019-04-04 | 2019-04-11 | R CODOX M | 02 | null | NILOTINIB | 100926406 |